2024-514656-32-00
CTIS ↗
Vaborem 1 g/1 g powder for concentrate for solution for infusion
Suspected or confirmed Gram negative infections
pharma · Dyslipidemia at High to Very High Cardiovascular Risk · Suspected or confirmed Gram negative infections
Menarini Asia-Pacific
A.Menarini Australia Pty Limited
Menarini Asia-Pacific trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Singapore, SG HQ
720 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Singapore, SG
- Employees
- 720
- Programs
- 2
- Drugs
- 15
- Patents
- 0
Menarini Asia-Pacific clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Menarini Asia-Pacific programs — each row shows trial ID, program name, phase, status, and indication.
Menarini Asia-Pacific trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Menarini Asia-Pacific.